FI875427A0 - Menetelmä valmistaa hevosen -interferonia - Google Patents

Menetelmä valmistaa hevosen -interferonia

Info

Publication number
FI875427A0
FI875427A0 FI875427A FI875427A FI875427A0 FI 875427 A0 FI875427 A0 FI 875427A0 FI 875427 A FI875427 A FI 875427A FI 875427 A FI875427 A FI 875427A FI 875427 A0 FI875427 A0 FI 875427A0
Authority
FI
Finland
Prior art keywords
gamma
eqifn
method produces
equine interferon
equine
Prior art date
Application number
FI875427A
Other languages
English (en)
Swedish (sv)
Other versions
FI99116C (fi
FI875427A (fi
FI99116B (fi
Inventor
Rudolf Hauptmann
Adolf Himmler
Peter Swetly
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI875427A0 publication Critical patent/FI875427A0/fi
Publication of FI875427A publication Critical patent/FI875427A/fi
Application granted granted Critical
Publication of FI99116B publication Critical patent/FI99116B/fi
Publication of FI99116C publication Critical patent/FI99116C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI875427A 1986-12-10 1987-12-10 Menetelmä valmistaa hevosen -interferonia FI99116C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863642096 DE3642096A1 (de) 1986-12-10 1986-12-10 Pferde-(gamma)-interferon
DE3642096 1986-12-10

Publications (4)

Publication Number Publication Date
FI875427A0 true FI875427A0 (fi) 1987-12-10
FI875427A FI875427A (fi) 1988-06-11
FI99116B FI99116B (fi) 1997-06-30
FI99116C FI99116C (fi) 1997-10-10

Family

ID=6315829

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875427A FI99116C (fi) 1986-12-10 1987-12-10 Menetelmä valmistaa hevosen -interferonia

Country Status (20)

Country Link
US (1) US5602010A (fi)
EP (1) EP0271824B1 (fi)
JP (3) JPS63233794A (fi)
KR (1) KR880007568A (fi)
AT (1) ATE91722T1 (fi)
AU (1) AU616873B2 (fi)
CA (1) CA1339776C (fi)
DE (2) DE3642096A1 (fi)
DK (1) DK170054B1 (fi)
ES (1) ES2058094T3 (fi)
FI (1) FI99116C (fi)
HU (1) HU213566B (fi)
IE (1) IE60404B1 (fi)
IL (1) IL84780A (fi)
NO (1) NO180239C (fi)
NZ (1) NZ222856A (fi)
PH (1) PH30889A (fi)
PT (1) PT86332B (fi)
SU (1) SU1701114A3 (fi)
ZA (1) ZA879245B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860001471B1 (ko) 1980-04-03 1986-09-26 비오겐 엔. 브이 인체의 섬유아세포 인터페론(IFN-β)폴리펩티드의 제조방법
US5272263A (en) 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
GB2291645A (en) * 1994-07-21 1996-01-31 Q One Biotech Ltd Equine gamma-interferon
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
AU2587002A (en) * 2000-11-03 2002-05-15 Biomedicines Inc Method for short-term and long-term drug dosimetry
US20030143197A1 (en) * 2001-11-09 2003-07-31 Moran S. Mark Method for treating diseases with omega interferon
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
DK2359808T3 (da) 2006-08-09 2013-08-05 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelaggregater
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
EP3733694A1 (en) 2016-05-16 2020-11-04 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE88622C (fi) *
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity

Also Published As

Publication number Publication date
KR880007568A (ko) 1988-08-27
JPH07258294A (ja) 1995-10-09
FI99116C (fi) 1997-10-10
CA1339776C (en) 1998-03-24
AU616873B2 (en) 1991-11-14
AU8223387A (en) 1988-06-30
ZA879245B (en) 1989-08-30
FI875427A (fi) 1988-06-11
EP0271824A3 (en) 1989-05-24
EP0271824B1 (de) 1993-07-21
DK170054B1 (da) 1995-05-08
ATE91722T1 (de) 1993-08-15
IL84780A0 (en) 1988-05-31
HU213566B (en) 1997-08-28
ES2058094T3 (es) 1994-11-01
SU1701114A3 (ru) 1991-12-23
DE3786649D1 (de) 1993-08-26
PT86332B (pt) 1990-11-07
PH30889A (en) 1997-12-23
NZ222856A (en) 1991-11-26
HUT46066A (en) 1988-09-28
IL84780A (en) 1992-11-15
PT86332A (de) 1988-01-01
IE60404B1 (en) 1994-07-13
NO180239B (no) 1996-12-02
NO875136D0 (no) 1987-12-09
DE3642096A1 (de) 1988-06-16
NO875136L (no) 1988-06-13
EP0271824A2 (de) 1988-06-22
JPS63233794A (ja) 1988-09-29
DK645887A (da) 1988-06-11
IE873342L (en) 1988-06-10
US5602010A (en) 1997-02-11
DK645887D0 (da) 1987-12-09
FI99116B (fi) 1997-06-30
JPH07250690A (ja) 1995-10-03
NO180239C (no) 1997-03-12

Similar Documents

Publication Publication Date Title
FI875427A0 (fi) Menetelmä valmistaa hevosen -interferonia
DK638887A (da) Syntetiske polypeptider og deres anvendelse til diagnosticering
DZ467A1 (fr) Interferon immunitaire urbain.
NO863000L (no) Fusjonsproteiner og fremgangsmaate til fremstilling derav.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
ATE109205T1 (de) Verbesserung der ausbeute bei der sekretion von disulfidverbrückten proteinen.
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
DE3855665D1 (de) Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
ATE103983T1 (de) Licht-induzierbarer promotor.
DK1241186T3 (da) Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH